Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors

Maria Sharmila A Sousa1, Flavia R M Latini, Hugo P Monteiro

  • 1Genetic Basis of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Federal University of São Paulo, 04039-032 São Paulo, SP, Brazil.

Insights

Arginase 2 (ARG2) promotes thyroid cancer by increasing eNOS expression and altering the cellular redox environment. Targeting ARG2 may offer a novel therapeutic strategy for thyroid tumors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Arginase 2 (ARG2) expression is elevated in malignant thyroid tumors but absent in normal tissues and benign lesions.
  • Understanding ARG2's role is crucial for identifying new therapeutic targets in thyroid cancer.

Purpose of the Study:

  • To investigate the functional role of ARG2 in thyroid carcinoma.
  • To elucidate the molecular mechanisms by which ARG2 influences tumor properties and intracellular environment.

Main Methods:

  • Small interfering RNA (siRNA) knockdown of ARG2 in a thyroid carcinoma cell line.
  • Analysis of eNOS and related gene expression (p21, Akt1, HIF-1, VEGF, CAV1).
  • Assessment of cellular properties including apoptosis and proliferation markers, nitric oxide (NO) production, and reactive oxygen species (ROS) levels.

Main Results:

  • ARG2 knockdown reduced eNOS and related gene expression, suppressed cell proliferation, and promoted apoptosis.
  • Silencing ARG2 altered the intracellular redox balance, affecting nitric oxide and ROS levels.
  • Genes involved in ROS/reactive nitrogen species metabolism (DUOX1, NOX4, SODs) were modulated by ARG2 knockdown.
  • A positive correlation between ARG2, eNOS, and related genes was observed in thyroid tumors.

Conclusions:

  • ARG2 and eNOS likely function coordinately in thyroid tumorigenesis and progression.
  • ARG2 plays a significant role in modulating the tumor microenvironment and cellular behavior.
  • Targeting ARG2 and eNOS pathways presents a potential therapeutic avenue for thyroid cancer.

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...